Insider transactions

EDGAR

BioVie Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
5 transactions, 25,780 shares
Sum of shares × price per share: 52,024.25
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–16 of 16

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-13 Filed 2026-11-16DO CUONG V Director · Officer: President CEO
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,5001.1625
2,906.25

Derived: shares × price per share. Exact value 2906.2500.

18,617Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price at which shares were purchased in several open market transactions on November 13, 2026, at prices ranging from $1.1600 to $1.1650, inclusive. The reporting person undertakes to provide BioVie Inc., any stockholder of BioVie Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001520138-26-000490 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-28Palumbo Joseph M Officer: Chief Medical Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)4,8432.16
10,460.88

Derived: shares × price per share. Exact value 10460.88.

6,036Direct (D) No
F1
  • F1 The shares of Common Stock were purchased in several open market transactions, all at the same price. The reported price does not reflect a weighted average price.
Open filing 0001520138-26-000383 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-28Chappell Amy Suzon Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)7272.16
1,570.32

Derived: shares × price per share. Exact value 1570.32.

727Direct (D) No
F1
  • F1 The shares of Common Stock were purchased by the Reporting Person in an open market transaction.
Open filing 0001520138-26-000382 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-28KIM JOANNE WENDY Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,5002.18
5,450

Derived: shares × price per share. Exact value 5450.00.

3,441Direct (D) No
F1
  • F1 The shares of Common Stock were purchased by the Reporting Person in an open market transaction.
Open filing 0001520138-26-000379 Read from the filing’s XML Dispute this row
2026-08-27 Filed 2026-08-28DO CUONG V Director · Officer: President CEO
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)15,2102.08
31,636.8

Derived: shares × price per share. Exact value 31636.80.

16,117Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price at which shares were purchased in several open market transactions on August 27, 2026, at prices ranging from $2.05 to $2.10, inclusive. The reporting person undertakes to provide BioVie Inc., any stockholder of BioVie Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001520138-26-000378 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09Palumbo Joseph M Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (132,000) — exercise price 1.31
Acquired (A)132,0000.00
0

Derived: shares × price per share. Exact value 0.00.

132,000Direct (D) No
F1
  • F1 55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029
Open filing 0001520138-26-000024 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09DO CUONG V Director · Officer: President CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (665,300) — exercise price 1.31
Acquired (A)665,3000—665,300Indirect (I) See FootnoteNo
F1, F2
  • F1 55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029.
  • F2 Securities are held in the name of Do Rickles Investments LLC.
Open filing 0001520138-26-000021 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09ROGICH SIGMUND Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (70,000) — exercise price 1.31
Acquired (A)70,0000—70,000Direct (D) No
F1
  • F1 The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.
Open filing 0001520138-26-000022 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09ROGICH SIGMUND Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (141,100) — exercise price 1.31
Acquired (A)141,1000—141,100Direct (D) No
F2
  • F2 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029.
Open filing 0001520138-26-000022 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09Farag Kameel D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying COMMON STOCK (57,500) — exercise price 1.31
Acquired (A)57,5000—57,500Direct (D) No
F1
  • F1 7,500 shares of the underlying options vest s on grant date and the remaining balance in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.
Open filing 0001520138-26-000019 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09KIM JOANNE WENDY Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (110,100) — exercise price 1.31
Acquired (A)110,1000.00
0

Derived: shares × price per share. Exact value 0.00.

110,100Direct (D) No
F1
  • F1 55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029.
Open filing 0001520138-26-000023 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09Chappell Amy Suzon Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (57,500) — exercise price 1.31
Acquired (A)57,5000—57,500Direct (D) No
F1
  • F1 7,500 shares underlying the options vest on grant date and the remaining balance will vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.
Open filing 0001520138-26-000018 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09Sherman Michael Edward Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (80,000) — exercise price 1.31
Acquired (A)80,0000—80,000Direct (D) No
F1
  • F1 The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.
Open filing 0001520138-26-000020 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09Sherman Michael Edward Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (341,100) — exercise price 1.31
Acquired (A)341,1000—341,100Direct (D) No
F2
  • F2 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029.
Open filing 0001520138-26-000020 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09Lang James Paul Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (90,000) — exercise price 1.31
Acquired (A)90,0000.00
0

Derived: shares × price per share. Exact value 0.00.

90,000Direct (D) No
F1
  • F1 The options vest in four equal installments on February 10, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.
Open filing 0001520138-26-000017 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-09Lang James Paul Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (330,500) — exercise price 1.31
Acquired (A)330,5000.000
0

Derived: shares × price per share. Exact value 0.000.

330,500Direct (D) No
F2
  • F2 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029.
Open filing 0001520138-26-000017 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-17. Prior quarter ending 2026-06-30: 9,164 filings read.

Showing 1–42 of 42

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
MORGAN STANLEY Partly reported under another manager1,048,722 SH1,594,058 dollarsHigher by 443,251 Prior quarter: 605,471Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
ARMISTICE CAPITAL, LLC 500,000 SH157,800 dollarsUnchanged Prior quarter: 500,000Open filing 0001315863-26-000784 Filed 2026-11-16 Dispute this row
Warberg Asset Management LLC 435,825 SH137,546 dollarsLower by 177,601 Prior quarter: 613,426Open filing 0001597506-26-000004 Filed 2026-11-02 Dispute this row
Diametric Capital, LP Partly reported under another manager411,337 SH129,817 dollarsLower by 595,299 Prior quarter: 1,006,636Open filing 0001719087-26-000008 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager231,311 SH82,836 dollarsHigher by 229,136 Prior quarter: 2,175Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager230,662 SH350,606 dollarsHigher by 194,802 Prior quarter: 35,860Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
Ionic Capital Management LLC 175,000 SH55,230 dollarsNot in the prior quarter’s filings read Open filing 0000929638-26-004330 Filed 2026-11-16 Dispute this row
HEIGHTS CAPITAL MANAGEMENT, INC Partly reported under another manager90,000 SH28,404 dollarsUnchanged Prior quarter: 90,000Open filing 0001081698-26-000009 Filed 2026-11-16 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager80,826 SH122 dollarsNot in the prior quarter’s filings read Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
PRELUDE CAPITAL MANAGEMENT, LLC 78,827 SH24,878 dollarsLower by 140,377 Prior quarter: 219,204Open filing 0000945621-26-001415 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager75,774 SH115,176 dollarsHigher by 5,022 Prior quarter: 70,752Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
STATE STREET CORP Partly reported under another manager73,103 SH111,117 dollarsNot in the prior quarter’s filings read Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 70,906 SH107,777 dollarsUnchanged Prior quarter: 70,906Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Greenland Capital Management LP 60,281 SH19,025 dollarsNot in the prior quarter’s filings read Open filing 0001896430-26-000007 Filed 2026-11-16 Dispute this row
PHILADELPHIA TRUST CO 50,010 SH76 dollarsUnchanged Prior quarter: 50,010Open filing 0001110806-26-000005 Filed 2026-11-05 Dispute this row
VANGUARD FIDUCIARY TRUST CO 37,557 SH57,087 dollarsUnchanged Prior quarter: 37,557Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager21,820 SH33,166 dollarsUnchanged Prior quarter: 21,820Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
GSA CAPITAL PARTNERS LLP 21,134 SH32 dollarsNot in the prior quarter’s filings read Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row
ARMSTRONG ADVISORY GROUP, INC 19,900 SH6,281 dollarsLower by 46,000 Prior quarter: 65,900Open filing 0001932952-26-000006 Filed 2026-10-09 Dispute this row
Ground Swell Capital, LLC 16,305 SH5,146 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002533 Filed 2026-11-09 Dispute this row
StoneX Group Inc. Partly reported under another manager15,983 SH26,434 dollarsNot in the prior quarter’s filings read Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row
TWO SIGMA SECURITIES, LLC 10,531 SH3,324 dollarsLower by 3,353 Prior quarter: 13,884Open filing 0000899140-26-001334 Filed 2026-11-16 Dispute this row
Allworth Financial LP 5,600 SH10,864 dollarsUnchanged Prior quarter: 5,600Open filing 0001140361-26-042358 Filed 2026-11-06 Dispute this row
Rockefeller Capital Management L.P. Partly reported under another manager5,000 SH7,600 dollarsNot in the prior quarter’s filings read Open filing 0001739439-26-000009 Filed 2026-11-13 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager4,427 SH6,729 dollarsHigher by 2,363 Prior quarter: 2,064Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
SBI Securities Co., Ltd. 1,667 SH2,534 dollarsHigher by 800 Prior quarter: 867Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
PNC Financial Services Group, Inc. Partly reported under another manager1,000 SH1,520 dollarsUnchanged Prior quarter: 1,000Open filing 0001193125-26-450808 Filed 2026-11-06 Dispute this row
Pinnacle Financial Group, Inc. 500 SH760 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128546 Filed 2026-11-16 Dispute this row
BFC Planning, Inc. 430 SH654 dollarsUnchanged Prior quarter: 430Open filing 0001420506-26-002645 Filed 2026-11-13 Dispute this row
NewEdge Advisors, LLC 10 SH15 dollarsUnchanged Prior quarter: 10Open filing 0001213900-26-119695 Filed 2026-11-13 Dispute this row
Tradewinds Capital Management, LLC 10 SH16 dollarsUnchanged Prior quarter: 10Open filing 0001616026-26-000008 Filed 2026-10-23 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager8 SH12 dollarsUnchanged Prior quarter: 8Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
Financial Perspectives, Inc 6 SH9 dollarsUnchanged Prior quarter: 6Open filing 0002003287-26-000005 Filed 2026-11-03 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager5 SH8 dollarsUnchanged Prior quarter: 5Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
HARBOUR INVESTMENTS, INC. 3 SH5 dollarsUnchanged Prior quarter: 3Open filing 0000810121-26-000006 Filed 2026-11-09 Dispute this row
Caitong International Asset Management Co., Ltd 2 SH3 dollarsLower by 12 Prior quarter: 14Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row
DANSKE BANK A/S 1 SH2 dollarsUnchanged Prior quarter: 1Open filing 0001104659-26-124081 Filed 2026-11-09 Dispute this row
ALBION FINANCIAL GROUP /UT Partly reported under another manager1 SH2 dollarsUnchanged Prior quarter: 1Open filing 0001054677-26-000006 Filed 2026-10-21 Dispute this row
BARCLAYS PLC Partly reported under another manager1 SH2 dollarsNot in the prior quarter’s filings read Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager1 SH2 dollarsUnchanged Prior quarter: 1Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
JONES FINANCIAL COMPANIES LLLP Partly reported under another manager1 SH2 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager0 SH0 dollarsLower by 1 Prior quarter: 1Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • MYDA Advisors LLC 159,800 SH
  • RENAISSANCE TECHNOLOGIES LLC 127,918 SH
  • CITADEL ADVISORS LLC 95,952 SH
  • Cambridge Investment Research Advisors, Inc. 27,632 SH
  • Persistent Asset Partners Ltd 14,996 SH
  • XTX Topco Ltd 14,228 SH
  • Caprock Group, LLC 11,300 SH
  • ROYAL BANK OF CANADA 400 SH
  • Integrated Wealth Concepts LLC 86 SH
  • MERCER GLOBAL ADVISORS INC /ADV 60 SH
  • BERTHEL, FISHER COMPANY FINANCIAL SERVICES, INC. 20 SH
  • WELLS FARGO COMPANY/MN 10 SH
  • FIFTH THIRD BANCORP 4 SH
  • GILL CAPITAL PARTNERS, LLC 2 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
JANE STREET GROUP, LLC Class A Common Stock, Par Value $0.0001 Per Share2.7230,662.0009/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 1Open filing 0001595888-26-000133 Dispute this row
Jane Street Capital, LLC Class A Common Stock, Par Value $0.0001 Per Share0.02,374.0009/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 1Open filing 0001595888-26-000133 Dispute this row
Jane Street Global Trading, LLC Class A Common Stock, Par Value $0.0001 Per Share2.6228,288.0009/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 1Open filing 0001595888-26-000133 Dispute this row
JANE STREET GROUP, LLC Class A Common Stock, $0.0001 par value per share5.2441,751.0008/28/2026 Filed 2026-09-03SCHEDULE 13GOpen filing 0001595888-26-000114 Dispute this row
Jane Street Capital, LLC Class A Common Stock, $0.0001 par value per share0.865,435.0008/28/2026 Filed 2026-09-03SCHEDULE 13GOpen filing 0001595888-26-000114 Dispute this row
Jane Street Global Trading, LLC Class A Common Stock, $0.0001 par value per share4.5376,316.0008/28/2026 Filed 2026-09-03SCHEDULE 13GOpen filing 0001595888-26-000114 Dispute this row
Alta Partners LLC Class A Common Stock8.4687,321.0008/12/2026 Filed 2026-08-19SCHEDULE 13GOpen filing 0001094891-26-000281 Dispute this row
Morgan Stanley Class A Common Stock11.9896,82207/31/2026 Filed 2026-08-07SCHEDULE 13G/AAmendment 1Open filing 0000895421-26-000215 Dispute this row
Morgan Stanley Smith Barney LLC Class A Common Stock11.9896,82207/31/2026 Filed 2026-08-07SCHEDULE 13G/AAmendment 1Open filing 0000895421-26-000215 Dispute this row
Morgan Stanley Class A Common Stock8.0605,47206/30/2026 Filed 2026-08-07SCHEDULE 13GOpen filing 0000895421-26-000214 Dispute this row
Morgan Stanley Smith Barney LLC Class A Common Stock8.0605,47206/30/2026 Filed 2026-08-07SCHEDULE 13GOpen filing 0000895421-26-000214 Dispute this row
DO CUONG V Class A Common Stock, par value $0.0001 per share5.03399,018.0001/05/2026 Filed 2026-03-25SCHEDULE 13DOpen filing 0001520138-26-000086 Dispute this row
Do Rickles Investments, LLC Class A Common Stock, par value $0.0001 per share5.02398,111.0001/05/2026 Filed 2026-03-25SCHEDULE 13DOpen filing 0001520138-26-000086 Dispute this row
ACUITAS GROUP HOLDINGS, LLC Class A Common Stock, par value $0.0001 per share15.83,043,574.0006/25/2025 Filed 2025-06-30SCHEDULE 13D/AAmendment 11Open filing 0001104659-25-064301 Dispute this row
TERREN S. PEIZER Class A Common Stock, par value $0.0001 per share15.83,050,394.0006/25/2025 Filed 2025-06-30SCHEDULE 13D/AAmendment 11Open filing 0001104659-25-064301 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,243,668 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
2022158,941
2023199,811
2024209,823
2025235,520
2026260,174

Filings made before the SEC required XML are listed, not extracted.

Back to BioVie Inc.